Crescendo Biologics
Laurie completed her undergraduate and DPhil studies with the Department of Biochemistry, University of Oxford before moving to industry to work on the generation of novel protein therapeutics. Prior to her current Business Development role, she held scientific positions at both Immunocore and Crescendo Biologics.
This person is not in any teams
This person is not in any offices
Crescendo Biologics
Crescendo Biologics is a biopharmaceutical company developing conditionally-activated T cell enhancing therapeutics, with a particular focus on CD137 (4-1BB).